Share Name Share Symbol Market Type
Gilead Sciences Inc NASDAQ:GILD NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.23 1.6% 78.21 75.79 78.15 79.47 76.36 77.41 19,457,772 05:00:02

Gilead Withdraws Application for Orphan-Drug Status

25/03/2020 9:41pm

Dow Jones News

Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart

1 Month : From Mar 2020 to Apr 2020

Click Here for more Gilead Sciences Charts.

By Tom Burton


Gilead Sciences Inc. withdrew its application to get orphan-drug status for its investigational coronavirus drug remdesivir, after public-interest groups and Vermont Sen. Bernie Sanders accused the company of improperly capitalizing on the national epidemic.

Gilead received the special status just this week from the Food and Drug Administration. The status would have conferred seven years of monopoly as well as tax benefits, but the company dropped the special status after objections were raised.

Orphan-drug status was created by law to apply to rare diseases affecting fewer than 200,000 people, where drugmakers might not have a financial incentive to develop medications.

Mr. Sanders, who is running in the Democratic presidential primary, called the special status "truly outrageous" and had called on the Trump administration to reverse the special status for the drug. The public-interest group Public Citizen said that if the drug proves useful against the new coronavirus, "the world cannot afford to have one manufacturer maintain a monopoly over it."

Gilead didn't immediately respond to a request for comment.


Write to Tom Burton at

(END) Dow Jones Newswires

March 25, 2020 17:26 ET (21:26 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

1 Year Gilead Sciences Chart

1 Year Gilead Sciences Chart

1 Month Gilead Sciences Chart

1 Month Gilead Sciences Chart
ADVFN Advertorial
Your Recent History
Gilead Sci..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200404 12:53:57